Reilly Financial Advisors’s Mesa Laboratories MLAB Stock Holding History

Reilly Financial Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$4K	Buy	+13	New	+$4.08K	﹤0.01%	894

Other funds holding MLAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Reilly Financial Advisors's MLAB Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Mesa Laboratories (MLAB) in Q4 2021: 13 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #894 among its holdings.

178 funds tracked by Wall St. Rank hold MLAB as of Q4 2021.

Reilly Financial Advisors held 13 shares of Mesa Laboratories worth $4K as of Q4 2021.
Mesa Laboratories was a new Reilly Financial Advisors position in Q4 2021.
Mesa Laboratories made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #894 holding.
178 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.